Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Aug 24, 2026
Document Date
Aug 20, 2026
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
LEONARD JOHN M